Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial

Georgina Venetia Long, Daniil Stroyakovskiy, Helen J Gogas et al. · The Lancet · 2015

Cited by 1,399 works. doi:10.1016/s0140-6736(15)60898-4

Authors

References